Catalyst Wire Dossier Catalyst Wire Dossier

Cell Medica cellular immunotherapy (EBV-targeted therapy)

· Cell Medica Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cell Medica cellular immunotherapy (EBV-targeted therapy), covering 2019-03-12 to 2019-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas [Phase 2]

See pricing